Maxime Dougados Selected Research

Rheumatic Diseases (Rheumatism)

5/2022	Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
1/2022	Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases.
6/2021	Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic.
1/2021	EULAR definition of difficult-to-treat rheumatoid arthritis.
1/2021	Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center.
10/2019	Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.
1/2019	Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.
12/2017	Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
6/2017	Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
6/2017	Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Dougados Research Topics

Disease

116	Rheumatoid Arthritis 01/2022 - 11/2002
57	Ankylosing Spondylitis 10/2022 - 09/2002
50	Axial Spondyloarthritis 11/2022 - 02/2011
44	Pain (Aches) 01/2022 - 02/2002
31	Inflammation (Inflammations) 01/2022 - 04/2005
28	Arthritis (Polyarthritis) 10/2022 - 03/2003
25	Back Pain (Backache) 01/2022 - 09/2005
22	Rheumatic Diseases (Rheumatism) 05/2022 - 12/2003
22	Osteoarthritis 07/2021 - 01/2003
22	Necrosis 01/2021 - 01/2005
21	Infections 10/2020 - 07/2006
16	Fatigue 01/2022 - 08/2003
13	Spondylarthropathies 01/2019 - 03/2002
12	Sacroiliitis 01/2021 - 11/2011
11	Non-Radiographic Axial Spondyloarthritis 01/2022 - 06/2013
10	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 07/2009
9	Psoriatic Arthritis 01/2022 - 11/2003
8	Uveitis 06/2022 - 04/2004
8	Knee Osteoarthritis 05/2014 - 10/2002
7	Chronic Disease (Chronic Diseases) 11/2020 - 08/2005
7	Hip Osteoarthritis (Coxarthrosis) 02/2014 - 02/2002
6	Synovitis 01/2022 - 04/2005
4	Osteoporosis 01/2020 - 09/2005
4	Body Weight (Weight, Body) 12/2015 - 11/2003
3	Rheumatic Fever (Acute Articular Rheumatism) 11/2020 - 12/2006
3	Crohn Disease (Crohn's Disease) 11/2020 - 12/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020 - 12/2014
3	Herpes Zoster 10/2020 - 07/2003
3	Neoplasms (Cancer) 01/2020 - 06/2010
3	Fibromyalgia (Fibrositis) 01/2019 - 01/2018
3	Hypertension (High Blood Pressure) 01/2018 - 12/2011
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2014 - 04/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 07/2012
2	COVID-19 04/2022 - 06/2021
2	Edema (Dropsy) 01/2022 - 07/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2015
2	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

43	Antirheumatic Agents (DMARD)IBA 06/2022 - 06/2004
37	Etanercept (Enbrel)FDA Link 10/2022 - 07/2003
32	Biological ProductsIBA 01/2022 - 09/2005
29	C-Reactive ProteinIBA 01/2022 - 11/2003
29	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 07/2003
28	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2003
27	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2005
23	Rituximab (Mabthera)FDA Link 06/2021 - 09/2006
18	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 12/2006
16	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022 - 09/2002
16	tocilizumab (atlizumab)FDA Link 04/2022 - 01/2013
16	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2020 - 11/2011
15	Pharmaceutical PreparationsIBA 01/2022 - 02/2002
15	Abatacept (Orencia)FDA Link 01/2020 - 08/2005
14	GlucocorticoidsIBA 01/2021 - 01/2006
13	Infliximab (Remicade)FDA Link 01/2020 - 03/2002
13	ametantrone (HAQ)IBA 11/2018 - 11/2003
12	Adalimumab (Humira)FDA Link 01/2020 - 07/2006
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2005
10	Certolizumab Pegol FDA Link 09/2020 - 12/2012
9	AntibodiesIBA 01/2016 - 01/2006
8	baricitinibIBA 01/2021 - 01/2017
8	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 06/2003
7	Biosimilar PharmaceuticalsIBA 01/2022 - 03/2014
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2006
7	Anti-Citrullinated Protein AntibodiesIBA 12/2014 - 09/2010
6	secukinumabIBA 01/2022 - 12/2015
6	golimumab FDA Link 01/2022 - 03/2014
5	Interleukin-17 (Interleukin 17)IBA 11/2022 - 01/2015
5	SteroidsIBA 01/2020 - 03/2007
5	Vitamin D FDA LinkGeneric 01/2020 - 05/2016
5	AntigensIBA 01/2020 - 11/2003
5	Monoclonal AntibodiesIBA 01/2019 - 07/2006
5	Prostaglandins AIBA 06/2018 - 11/2006
5	Rheumatoid FactorIBA 01/2016 - 07/2006
4	Guanosine Diphosphate (GDP)IBA 01/2022 - 04/2016
4	tofacitinibIBA 01/2021 - 06/2017
4	Janus Kinase InhibitorsIBA 01/2021 - 06/2017
4	ixekizumabIBA 12/2020 - 12/2018
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2003
3	Janus KinasesIBA 10/2020 - 06/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 12/2018
3	VaccinesIBA 01/2020 - 01/2019
3	CytokinesIBA 01/2020 - 07/2015
3	EnzymesIBA 12/2016 - 06/2004
3	Immunoglobulin M (IgM)IBA 01/2016 - 12/2007
3	Immunoglobulin G (IgG)IBA 01/2016 - 07/2006
3	Interleukin-6 (Interleukin 6)IBA 07/2015 - 04/2013
3	Peptides (Polypeptides)IBA 12/2014 - 03/2013
3	cyclic citrullinated peptideIBA 10/2013 - 01/2006
3	amsonic acid (DAS)IBA 03/2012 - 12/2003
2	bimekizumabIBA 07/2022 - 01/2020
2	InterleukinsIBA 01/2020 - 01/2020
2	drotaverin (No-spa)IBA 01/2020 - 11/2015
2	clazakizumabIBA 01/2020 - 06/2017

Therapy/Procedure

71	Therapeutics 05/2022 - 11/2002
6	Replacement Arthroplasty 01/2016 - 11/2003
5	Biological Therapy 05/2022 - 10/2013
5	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2009 - 02/2002
4	Injections 01/2020 - 04/2005
3	Aftercare (After-Treatment) 01/2019 - 10/2010
2	Drug Tapering 09/2020 - 01/2020